Carbon Radioisotopes

Name
Carbon Radioisotopes
Accession Number
DBCAT000799
Description

Not Available

Drugs
DrugDrug Description
CarfentanilCarfentanil is similar (but more potent) to the opioid analgesic fentanyl. It is used as a tranquilizer for large animals.
S-MethylcysteineNot Available
HexaminolevulinateAn optical imaging agent used to perform Blue Light Cystoscopy (BLCâ„¢) in order to detect carcinoma of the bladder.
CutamesineInvestigated for use/treatment in strokes and depression.
TalopramTalopram is a selective norepinephrine reuptake inhibitor (SNRI) that is structurally similar to citalopram and melitracen. It was researched in the 1960s and 1970s but never marketed.
BMS-690514BMS-690514 has been investigated for the treatment of Breast Cancer.
TanzisertibTanzisertib has been used in trials studying the treatment of Fibrosis, Discoid Lupus, Pulmonary Fibrosis, Interstitial Lung Disease, and Lung Diseases, Interstitial, among others.
RRx-001RRx-001 has been used in trials studying the treatment of Lymphomas, Brain Metastases, Cholangiocarcinoma, Colorectal Neoplasms, and Malignant Solid Tumor, among others.
LaniquidarLaniquidar has been used in trials studying the treatment of Breast Cancer.
VorozoleNot Annotated
5-fluorotryptophan5-fluorotryptophan can be used as substrate analogue to study enzyme mechanisms by NMR spectroscopy.
SB-649868SB-649868 is under investigation in clinical trial NCT01030939 (Study to Investigate Safety, Tolerability, Pharmacokinetics and Cardiac Function After Repeat Doses of SB-649868 in Healthy-volunteers).
MartinostatMartinostat is under investigation in clinical trial NCT03721211 (Imaging With [11C]Martinostat in Breast Cancer).
Pittsburgh Compound BPittsburgh Compound B is under investigation in clinical trial NCT01723553 (Amyloid-related Imaging Abnormalities (Microbleeds) in Atypical AD).
ORM-13070 C-11ORM-13070 C-11 is under investigation in clinical trial NCT00735774 (Suitability of 11C-ORM-13070 as a PET Tracer).
Carfentanil, C-11Carfentanil, C-11 is under investigation in clinical trial NCT01899170 (Towards Individualized Deep Brain Stimulation Treatment of Chronic Neuropathic Pain).
Drugs & Drug Targets
DrugTargetType
CarfentanilMu-type opioid receptortarget
CarfentanilKappa-type opioid receptortarget
CarfentanilDelta-type opioid receptortarget
S-MethylcysteineCathepsin Dtarget
S-MethylcysteineFatty acid-binding protein, livercarrier
S-MethylcysteineMethylated-DNA--protein-cysteine methyltransferasetarget
LaniquidarP-glycoprotein 1transporter
5-fluorotryptophanTriosephosphate isomerasetarget
5-fluorotryptophanGlutathione S-transferase Mu 1target